Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is GBX 1,993.33 ($26.33).
Several equities analysts recently weighed in on JMAT shares. Berenberg Bank restated a “hold” rating and issued a GBX 1,800 ($23.78) price objective on shares of Johnson Matthey in a report on Tuesday, June 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 2,400 ($31.70) target price on shares of Johnson Matthey in a research note on Monday, June 24th.
View Our Latest Analysis on JMAT
Johnson Matthey Trading Down 0.1 %
Insider Transactions at Johnson Matthey
In related news, insider Stephen Oxley acquired 21 shares of the stock in a transaction dated Wednesday, August 21st. The stock was bought at an average price of GBX 1,603 ($21.18) per share, with a total value of £336.63 ($444.69). Insiders purchased 66 shares of company stock valued at $107,901 over the last quarter. Corporate insiders own 0.61% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Comparing and Trading High PE Ratio Stocks
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Consumer Discretionary Stocks Explained
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- How to Find Undervalued Stocks
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.